Medication Assisted Treatment Therapies
On October 8, 2002, the Schedule III narcotic medications Subutex (buprenorphine hydrochloride) and Suboxone tablets(buprenorphine hydrochloride and naloxone hydrochloride) received FDA approval for the treatment of opioid addiction.
CSAT's Division of Pharmacologic Therapies
CSAT's Division of Pharmacologic Therapies (DPT) manages the day-to-day regulatory oversight activities necessary to implement new SAMHSA regulations (42 CFR Part 8) on the use of opioid agonist medications (methadone and LAAM) approved by the Food and Drug Administration (FDA) for addiction treatment.
Buprenorphine Treatment Locator
The Physician Locator is an online resource designed to assist the States, medical and addiction treatment communities, potential patients, and/or their families in finding information on locating physicians who can prescribe buprenorphine (Suboxone and Subutex) for treatment of opioid addiction.
Methadone Treatment Locator
The Opioid Treatment Program Directory is an online resource designed to assist States, medical and addiction treatment communities, potential patients, and/or their families in finding information on locating methadone treatment for opioid addiction treatment and recovery.